New data generation
& Application of 2
EADA Business school
Market analysis &
Program that helps European research teams launch successful diagnostic innovations to improve health and patient care
Ayudas para financiar estudios de viabilidad de las innovaciones en Salud
Chief Financial Officer
AtG’s business model consists of de-risking AtG-101 and its Companion Diagnostic from a Proof of Concept Development Stage into a successful Phase I/II product and then Licensing it to a Pharmaceutical company.
AtG is currently looking for investors in order to fund the preclinical development of AtG-101.
Would it be you?